Breaking News

Bosch Packaging Appoints New Leadership

November 13, 2012

Harbauer, Häcki, Kang head ops in Germany, Switzerland and China

Uwe Harbauer has been appointed senior vice president, Business Unit Pharma at Bosch Packaging Technology in Crailsheim, Germany, effective January 1, 2013. He replaces Wolfgang Szczerba, who will retire after 34 years at the company.
 
Walter Häcki succeeds Mr. Harbauer as senior vice president of Packaging Services in Beringen, Switzerland. Mr. Harbauer joined Bosch Packaging Technology in 2000. He has extensive experience as head of sales of the Pharma business unit, and as senior vice president in charge of customer service.
 
Mr. Häcki previously was responsible for Bosch Packaging Technology’s Chinese locations in Hangzhou (Zhejiang province) and Chengdu (Sichuan province). Chee Kiang Kang succeeds Mr. Häcki in China. Mr. Kang worked as site manager in Singapore and has gained experience as a product manager in Germany in preparation for his new functions in China.
 
Friedbert Klefenz, president of Bosch Packaging Technology, said, “These appointments once again underline the long-term orientation of Bosch Packaging Technology. Both business units, as well as the entire division, will profit from long-term and international experience of their new managers.”

Related Contract Manufacturing:

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks